Tapiola, Tero <br/><br/>
Cerebrospinal fluid -amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.  [electronic resource] 

 -  Archives of neurology  Mar 2009 
 - 382-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-3687 
<br/><br/><label>Standard No.: </label>10.1001/archneurol.2008.596  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alzheimer Disease--cerebrospinal fluid<br/>Amyloid beta-Peptides--cerebrospinal fluid<br/>Apolipoproteins E--genetics<br/>Brain--pathology<br/>Cross-Sectional Studies<br/>Dementia--cerebrospinal fluid<br/>Female<br/>Humans<br/>Immunoassay--methods<br/>Logistic Models<br/>Male<br/>Nervous System Diseases--cerebrospinal fluid<br/>Peptide Fragments--cerebrospinal fluid<br/>Plaque, Amyloid--pathology<br/>ROC Curve<br/>Retrospective Studies<br/>Silver Staining--methods<br/>Statistics, Nonparametric<br/>tau Proteins--cerebrospinal fluid